Summary. An intravenous injection of 2-fluoro-oestradiol simultaneously with an implantation-inducing dose of oestradiol reduced the number of implantation sites in delayed implanting hypophysectomized rats maintained with progesterone. Administration of 2-fluoro-oestradiol 1 h before or after oestradiol had no effect. Furthermore, injection of as much as 500 ng 2-fluoro-oestradiol 48 h before administration of oestradiol failed to have any effect upon implantation, i.e. failure to block implantation was correlated with failure to induce the uterine refractory state. These results suggest that conversion of primary oestrogens to catechol oestrogens could be important for implantation as well as for the induction of the oestrogen refractory state in the uterus.
Introduction
In the rat implantation of the blastocyst into a progesterone-primed uterus requires the action of oestrogen (Psychoyos, 1973 (Psychoyos, , 1974 . The nature and mechanism of this oestrogenic action are unde¬ fined, but the oestrogenic action in implantation could be mediated via catechol oestrogens Dey et ai, 1986 ), which are a major group of active metabolites formed by aromatic hydroxylation of phenolic oestrogens at the carbon 2 or 4 position. 2-Fluoro-oestradiol, which is a potent oestrogen in terms of many of the receptor-mediated actions of oestrogen, is a poor substrate for catechol oestrogen formation (Krey et ai, 1980) and does not induce implantation in the delayed implanting rat even when used in high dosage (Dey et ai, 1986) . Furthermore, 2-fluoro-oestradiol acts as an inhibitor of oestrogen-2-hydroxylase (50% inhibitory concentration = 10 µ ) in pig blastocysts when tested in vitro (unpublished data). In the present study the effect of 2-fluoro-oestradiol on implantation and the uterine refractory state that are usually induced by oestradiol was determined in delayed implanting rats.
Materials and Methods
Adult (250-275 g) rats (Holtzman Company, Madison, WI) were hypophysectomized, under ether anaesthesia, on Day 3 of pregnancy (morning of the day of finding vaginal spermatozoa is Day 1), using the parapharyngeal approach. A 5% solution of glucose was provided for drinking water after this operation. At the time of the operation and daily thereafter the animals received (subcutaneously) 2 mg progesterone (Sigma Chemical Co., St Louis, MO) dissolved in 0-1 ml sesame seed oil. On the 5th day of treatment (Day 8 of pregnancy) the animals were lightly anaesthetized with ether before being injected (intravenously; i.v.) with oestradiol (Sigma) and/or 2-fluoro-oestradiol. 2-Fluoro-oestradiol was prepared and generously provided by Dr J. G. Liehr (University of Texas Health Science Center, Galveston, TX). Analyses by direct inlet mass spectrometry and gas chromatography-mass spectrometry indicated that the compound was free of oestradiol but it contained about 2% of another fluorinated oestradiol, possibly 4-fluoro-oestradiol. The steroids were dissolved in ethanol and diluted with saline just before use. One group of 6 animals received oestradiol 1 h before and another group of 5 rats received the oestradiol 1 h after a dose of 300 ng 2-fluoro-oestradiol.
*Reprint requests to Dr S. K. Dey.
In a separate experiment, animals received (i.v.) various doses of 2-fluoro-oestradiol 2 days before being injected (i.v.) with oestradiol. At 24 h after the administration of oestradiol all animals were injected (i.v.) with 0-5 ml of a 1% solution of Chicago Blue (Sigma) in 015 M-NaCl 15 min before being killed by an overdose of ether. The implan¬ tation sites were delineated by the extravasation of the blue dye secondary to increased capillary permeability (Psychoyos, 1973 (Dey et ai, 1986) . In the present study, 15 females treated with 30 ng oestradiol each had about 11 implantation sites (Table 1) . When 300 ng 2-fluoro-oestradiol were administered just before the dose of 30 ng oestradiol, none of the 7 females exhibited implantation sites but they did have a normal number of blastocysts in their uteri. Increasing the dose of oestradiol to 40 ng while keeping the dose of 2-fluoro-oestradiol at 300 ng resulted in implantation in 33% of the rats. The percentage dropped to 14% when the dose of 2-fluoro-oestradiol was raised to 500 ng and given just before 40 ng oestradiol. When the 300 ng 2-fluoro-oestradiol was given 1 h before or after the oestradiol, all animals had sites.
In the second experiment, all animals were given 50 ng oestradiol 2 days after the adminis¬ tration of 2-fluoro-oestradiol (Table 1) . Doses of the latter compound as high as 500 ng had no effect upon the implantation-inducing action of oestradiol. ÍCompounds administered essentially simultaneously.
Discussion
Substitution of fluorine on carbon 2 of the oestradiol molecule produces a compound that can mimic oestradiol in many actions except in the initiation of implantation. We previously postulated ) that conversion of the oestrogen to a catechol was necessary for induction of implantation, but 2-fluoro-oestradiol is a poor substrate for oestrogen-2/4-hydroxylase and it is doubtful that significant amounts of 2-hydroxyoestradiol can be produced (Krey et ai, 1980) . The question is whether 2-fluoro-oestradiol interferes with aromatic hydroxylation of oestradiol. Our observations on pig blastocysts and those of others upon rat liver indicate that 2-halo-oestrogens are potent inhibitors of oestrogen-2-hydroxylase (Brueggemier & Kimball, 1983) . These observations are consistent with our present finding that the implantation-inducing effect of oestradiol was compromised by the simultaneous presence of 2-fluoro-oestradiol. However, interference of oestra¬ diol action by 2-fluoro-oestradiol in implantation is short lived, because treatment with the latter compound 1 h before or after oestradiol was completely ineffective in altering implantation. There is no doubt that 2-fluoro-oestradiol binds to the cytosolic-nuclear receptor and exhibits many receptor-mediated oestrogenic actions (Krey et ai, 1980; Katzenellenbogen et ai, 1980; Liehr et ai, 1986) . Because this compound fails to induce implantation (Dey et ai, 1986) it is suggested that oestrogen interaction with the classical receptor is not the sole mediator of oestrogen action for implantation. Not only does 2-fluoro-oestradiol not induce implantation, it does not induce the uterine refrac¬ tory state. However, it is not surprising that an oestrogen that cannot induce uterine receptivity also fails to induce the post-receptive refractoriness. Uterine receptivity for blastocyst implantation is time-and hormone-dependent (Psychoyos, 1974; Yoshinaga, 1980) 
